All Releases All Releases MAR Regulatory Releases Selected Company Releases News Category AllAll ReleasesMAR Regulatory ReleasesSelected Company Releases Year All202620252024202320222021202020192018 May 29, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities May 29, 2026 Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema May 28, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities May 15, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities May 14, 2026 Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors May 11, 2026 Oculis Reports Q1 2026 Financial Results and Provides Company Update May 7, 2026 Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial May 5, 2026 Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting May 1, 2026 Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Apr 21, 2026 Oculis Publishes Invitation to the Annual General Meeting
